Dr. Firdaus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
11140 Montgomery Rd
Suite 200
Cincinnati, OH 45249Phone+1 513-321-4333Fax+1 513-533-6033- Is this information wrong?
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 2001 - 2004
Advocate Health Care/Advocate Lutheran General HospitalResidency, Internal Medicine, 1996 - 1999
Des Moines University College of Osteopathic MedicineClass of 1995
Certifications & Licensure
KY State License 2016 - 2025
OH State License 1999 - 2025
IN State License 2020 - 2025
IL State License 1996 - 1999- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary Start of enrollment: 2009 Feb 01
Publications & Presentations
PubMed
- 61 citationsA randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancerZishuo Ian Hu, Johanna C. Bendell, Andrea J. Bullock, Noelle K. LoConte, Hassan Hatoum, Paul S. Ritch, Hugo Hool, Joseph W. Leach, James Sanchez, Davendra Sohal, John ...> ;Cancer Medicine. 2019 Sep 1
- 38 citationsA Phase II Randomized Trial (GO27827) of First‐Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal CancerJohanna C. Bendell, Howard S. Hochster, Lowell L. Hart, Irfan Firdaus, Joseph R. Mace, Joshua J. McFarlane, Mark Kozloff, Daniel V.T. Catenacci, Jessie J. Hsu, Stephen...> ;The Oncologist. 2017 Mar 1
- 16 citationsPhase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction exp...Khaldoun Almhanna, Maria Luisa Limon Miron, David Wright, Antonio Cubillo Gracian, Richard A. Hubner, Jean-Luc Van Laethem, Carolina Muriel Lopez, Maria Alsina, Freder...> ;Investigational New Drugs. 2017 Feb 11
- Join now to see all
Press Mentions
New Collaboration at Christ Hospital Is Changing the Way Doctors Diagnose and Treat Cancer PatientsNovember 18th, 2022
Hospital Affiliations
Christ HospitalCincinnati, Ohio
Bethesda North HospitalCincinnati, Ohio- Kettering Health HamiltonHamilton, Ohio
The Jewish Hospital - Mercy HealthCincinnati, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
